Profusa, Inc. (PFSA)

NASDAQ: PFSA · Real-Time Price · USD
1.430
-0.590 (-29.21%)
At close: Jul 15, 2025, 4:00 PM
1.490
+0.060 (4.20%)
After-hours: Jul 15, 2025, 7:59 PM EDT
-29.21%
Market Cap 47.19M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 33.00M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,625,342
Open 1.750
Previous Close 2.020
Day's Range 1.350 - 1.780
52-Week Range 1.350 - 2.400
Beta 0.03
Analysts n/a
Price Target n/a
Earnings Date n/a

About PFSA

Profusa, Inc. designs and develops tissue-integrated sensors and biosensors that help in diabetes management. Additionally, the company develops software to offer biofeedback for chronic disease management and healthy living and monitoring of real-time body chemistries. Profusa, Inc. was incorporated in 2009 and is based in Emeryville, California. [Read more]

Founded 2009
Employees 15
Stock Exchange NASDAQ
Ticker Symbol PFSA
Full Company Profile

News

Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq

Profusa's Common Stock is Expected to Begin Trading on Nasdaq on Monday, July 14, 2025 Under the Ticker "PFSA" BERKELEY, Calif, July 11, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Compa...

4 days ago - GlobeNewsWire